Macy's new focus pushes up profit

A new report shows the retailer's sales gains came at J.C. Penney's expense.

The Associated Press
August 12, 2010 at 12:25AM

NEW YORK - Macy's Inc.'s net income surged in the second quarter as the department store chain saw a payoff from its focus on exclusive moderate-price fashions and tailoring merchandise to local markets.

The company, based in Cincinnati, boosted its profit outlook and increased its forecast for a key revenue measure as it takes market share from rivals such as J.C. Penney.

"We don't have a crystal ball on the economy, but we do have confidence that we can continue to gain share profitably, no matter the environment," Karen Hoguet, Macy's chief financial officer, told investors during a conference call Wednesday.

Winning signs

The indications that Macy's will be a clear winner as retailers' earnings season gets underway drove its stock up $1.14, or 5.9 percent, to close at $20.52 Wednesday.

The chain said Wednesday that it posted net income of $147 million, or 35 cents per share, for the period ended July 31. That compares with $7 million, or 2 cents per share, in the same period last year.

Revenue rose 7.2 percent to $5.54 billion. For the quarter, revenue at stores opened at least a year increased 4.9 percent. Revenue at stores opened at least a year is considered a key measure of a retailer's health.

Analysts surveyed by Thomson Reuters had expected 28 cents per share on revenue of $5.5 billion.

Macy's is expected to be among only a few bright spots in the pile of retailers' second-quarter earnings reports. After a surprise pickup in consumer spending earlier in the year, most retailers have seen a slowdown since April as the economic recovery is stalling and the job market remains stagnant.

With shoppers keeping a lid on spending, any sales gains are coming at the expense of other retailers. In fact, July's revenue reports released last week showed that Macy's better-than-expected sales is coming at the expense of J.C. Penney Co., which reported a surprise decline and warned that its second-quarter net income will come at the end of its previous forecast. The figure was based on revenue at stores opened at least a year.

about the writer

about the writer

ANNE D'INNOCENZIO

More from Business

See More
card image
Provided by Exact Sciences

The late Dr. David Ahlquist co-invented ColoGuard, which is helping drive Abbott Laboratories’ acquisition of Exact Sciences. After an ALS diagnosis in 2019, Ahlquist wasn’t done inventing.

card image
card image